Lilly extends tender offer to acquire Point Biopharma to Dec 1

POINT Biopharma Global

17/11/2023 11:59

Nov 17 (Reuters) - Eli Lilly  LLY.N  said on Friday it
was extending the deadline for its tender offer for Point
Biopharma  PNT.O  shares to Dec. 1, from Nov. 16 previously.
    In October, Lilly agreed to acquire the company in an
all-cash deal valued at $1.4 billion.
    

 (Reporting by Sriparna Roy in Bengaluru)
 ((Sriparna.Roy@thomsonreuters.com;))